References
Original article
Cortes, J. et al. Pembrolizumab plus chemotherapy in advanced triple-negative breast cancer. N. Engl. J. Med. 387, 217–226 (2022)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Romero, D. KEYNOTE-355 — OS benefit now reported. Nat Rev Clin Oncol 19, 616 (2022). https://doi.org/10.1038/s41571-022-00674-6
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41571-022-00674-6
- Springer Nature Limited
This article is cited by
-
Breast cancer organoids and their applications for precision cancer immunotherapy
World Journal of Surgical Oncology (2023)